Aerpio Therapeutics, Inc. — Form D/A

Aerpio Therapeutics, Inc. of CINCINNATI, OH, a company, filed a Form D amendment with the SEC on 2013-09-12. The offering totals $21.9M, of which $18.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
John H RiceDirectorBethesda, MD
Ian AW HowesExecutive OfficerSeattle, WA
Joseph H GardnerDirectorCincinnati, OH
Joseph H GardnerExecutive OfficerCincinnati, OH
Paul H WeissDirectorCincinnati, OH
Campbell H MurrayDirectorCincinnati, OH
Duane H NashDirectorCincinnati, OH
Steve H PakolaExecutive OfficerCincinnati, OH
Reinhard H AmbrosDirectorCincinnati, OH
Anupam H DalalDirectorCincinnati, OH
Chau H KhuongDirectorCincinnati, OH
Adrienne H GravesDirectorCincinnati, OH
Kevin H PetersExecutive OfficerCincinnati, OH
Muneer H SatterDirectorCincinnati, OH
Lauren H SilvermanDirectorCincinnati, OH
Robert H ShalwitzExecutive OfficerCincinnati, OH
William H DalyExecutive OfficerCincinnati, OH
Alan H FishmanExecutive OfficerCincinnati, OH
Kevin AW PetersExecutive OfficerCincinnati, OH
Adrienne AW GravesDirectorCincinnati, OH
Campbell AW MurrayDirectorCincinnati, OH
John AW RiceDirectorCincinnati, OH
Robert AW ShalwitzExecutive OfficerCincinnati, OH
Anupam AW DalalDirectorCincinnati, OH
Paul AW WeissDirectorCincinnati, OH

Other filings by this issuer (6)

FiledFormOfferingSold
2016-11-14D$4.6M$3.5M
2016-04-15D$9.2M$4.5M
2014-05-06D$22.0M$22.0M
2013-11-15D/A$31.0M$27.0M
2012-11-16D$21.9M$10.0M
2012-01-05D$5.0M$5.0M

More